BlueAllele – Medical Alley Association

BlueAllele Corporation Receives Patent for Advanced Gene Editing Technology

Oakdale, MN — BlueAllele Corporation, a biotechnology company focused on advancing transformational gene correction technologies, announced today that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 11,091,756 (the ‘756 Patent), directed to the use of BlueAllele’s foundational PALIDON technology. BlueAllele’s PALIDON repair templates feature a palindromic, bi-directional structure that is […]

In the Know: Healthcare News for August 10, 2020

Mayo’s plasma program shows first signs of COVID-19 benefit University of Minnesota turns natural killer cells against COVID-19 FDA approves new Medtronic neurostim leads Best Buy’s health chief to step down, will remain an advisor as company pursues long-term ambitions Rival drugmakers launch joint trial of medicines for COVID-19  Cantel Medical names new president Walking […]

BlueAllele Launches PALIDON™ Gene Editing Technology to Discover and Develop Therapies for Genetic Diseases

Oakdale, Minnesota, July 23 — BlueAllele, a biotechnology company focused on enhancing the quality and precision of gene editing systems for patients with genetic diseases, announced the launch of PALIDON™, an innovative and proprietary repair template technology. Many rare genetic diseases are caused by mutations within a single gene. However, the location of the mutation often […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER